ASHLEI WILLIS: Open Payments
NPI 1871248476 · ZANESVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$651 in 30 payments from 17 companies in 2025. Trend: 2023 $24 · 2024 $132 · 2025 $651
Food & beverage: $651
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 2 | $85 |
| Neurocrine BioSciences, Inc. | 4 | $77 |
| ABBVIE INC. | 3 | $64 |
| Lundbeck LLC | 3 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| Regeneron Healthcare Solutions, Inc. | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 1 | $32 |
| Corium, LLC | 1 | $30 |
Products named: REZDIFFRA, INGREZZA, REXULTI, CAPLYTA, ENTYVIO, DUPIXENT, VOQUEZNA, Azstarys.
Industry payments across OH — which companies pay providers there.
